Maze Therapeutics Inc. (MAZE) at a glance

Maze Therapeutics Inc. (MAZE) is a Healthcare company. It trades at $23.73. It does not pay a dividend. Vestovix scores it 49/100 overall. Its strongest dimension is Safety (60/100) and its weakest is Momentum (36/100).

Price
$23.73
Market cap
n/a
P/E ratio
n/a
Dividend yield
None
Beta
n/a
52-week range
$9.83 to $53.65
Vestovix Score49/ 100How this works
Value
50
Growth
50
Income
40
Safety
60
Momentum
36